{"id":"lactobacillus-lb","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbance (bloating, gas)"},{"rate":null,"effect":"Mild abdominal discomfort"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This live biotherapeutic product colonizes the intestinal tract and produces metabolites that support beneficial microbiota composition, enhance intestinal barrier function, and promote local and systemic immune tolerance. By restoring or maintaining healthy microbial balance, it may reduce pathogenic bacterial overgrowth and associated inflammatory responses.","oneSentence":"Lactobacillus LB is a probiotic bacterium that modulates the gut microbiota and intestinal immune function to promote gastrointestinal health.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:51:35.128Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Gastrointestinal health maintenance"},{"name":"Microbiota restoration"}]},"trialDetails":[{"nctId":"NCT07471659","phase":"NA","title":"Effect of Daily Humiome® Post LB Intake on Wellbeing in Older Individuals With Moderate Stress Levels","status":"NOT_YET_RECRUITING","sponsor":"dsm-firmenich Switzerland AG","startDate":"2026-03-01","conditions":"Stress","enrollment":200},{"nctId":"NCT07110896","phase":"NA","title":"Study Evaluating the Effect of Humiome® Post LB on Stress, Anxiety, and Cognition in Aging Adults","status":"RECRUITING","sponsor":"dsm-firmenich Switzerland AG","startDate":"2025-08-01","conditions":"Healthy Aging","enrollment":236},{"nctId":"NCT06937814","phase":"NA","title":"The Effect of Humiome® Post LB on Gut COMFort in healthY Adult Volunteers","status":"RECRUITING","sponsor":"dsm-firmenich Switzerland AG","startDate":"2025-06-16","conditions":"GI Issues, Bowel Movements, Gastrointestinal Symptoms","enrollment":250},{"nctId":"NCT05433857","phase":"PHASE2","title":"Probiotics in Systemic Lupus Erythematosus","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-06-10","conditions":"Systemic Lupus Erythematosus","enrollment":40},{"nctId":"NCT04053790","phase":"PHASE4","title":"Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)","status":"COMPLETED","sponsor":"Hospital General de Mexico","startDate":"2019-01-15","conditions":"Irritable Bowel Syndrome With Diarrhea","enrollment":177},{"nctId":"NCT04167995","phase":"EARLY_PHASE1","title":"Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-06-09","conditions":"Inattentive, Hyperactivity, Impulsivity","enrollment":80},{"nctId":"NCT05123651","phase":"NA","title":"Research on the Characteristics and Application of Lactobacillus Rhamnosus X253 as Oral Probiotics","status":"COMPLETED","sponsor":"Junlebao Dairy Group Co., Ltd.","startDate":"2020-11-01","conditions":"Dental Caries","enrollment":60},{"nctId":"NCT03416595","phase":"NA","title":"A Study on Efficacy of Feeding N1115 Probiotic Supplement to Young Children","status":"UNKNOWN","sponsor":"Junlebao Dairy Group Co., Ltd.","startDate":"2017-09-18","conditions":"Intestinal Growth of Young Children","enrollment":60},{"nctId":"NCT01778699","phase":"PHASE4","title":"Anticaries Effect of Probiotic Lactobacillus Brevis CD2 (Lb CD2).","status":"UNKNOWN","sponsor":"Università degli Studi di Sassari","startDate":"2013-02","conditions":"Dental Caries, Gingivitis","enrollment":440},{"nctId":"NCT00700557","phase":"PHASE4","title":"Probiotics at the Treatment of Antibiotic Associated Diarrhea","status":"COMPLETED","sponsor":"Federal University of Uberlandia","startDate":"2006-10","conditions":"Antibiotic-Associated Diarrhea","enrollment":70}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":104,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lactobacillus fermentum + lactobacillus delbrueckii, lyophilized powder","Lacteol"],"phase":"marketed","status":"active","brandName":"lactobacillus LB","genericName":"lactobacillus LB","companyName":"Hospital General de Mexico","companyId":"hospital-general-de-mexico","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lactobacillus LB is a probiotic bacterium that modulates the gut microbiota and intestinal immune function to promote gastrointestinal health. Used for Gastrointestinal health maintenance, Microbiota restoration.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}